<DOC>
	<DOCNO>NCT02121444</DOCNO>
	<brief_summary>This study aim investigate adherence therapy among patient treat Betaferon use BETACONNECT autoinjector .</brief_summary>
	<brief_title>BAY86-5046 ( Betaseron ) , Non Interventional Studies</brief_title>
	<detailed_description />
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Patients diagnosis relapse remit multiple sclerosis clinically isolated syndrome . Patients must treatment Betaferon decision treat patient Betaferon make attend physician . Patient attend physician must agree usage BETACONNECT autoinjector device Written inform consent must obtain . Patients receive disease modify drug . Contraindications Betaferon describe Summary Product Characteristics .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>RRMS</keyword>
	<keyword>CIS</keyword>
</DOC>